Search
01/11/2023
A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes
Santos, JR, Domingo, P, Portilla, J, Gutiérrez, F, Imaz, A, Vilchez, H, Curran, A, Valcarce-Pardeiro, N, Payeras, A, Bernal, E, Montero-Alonso, M, Yzusqui, M, Clotet, B, Videla, S, Moltó, J, Paredes, R. A Randomized Trial of Dolutegravir Plus Darunavir/Cobicistat as a Switch Strategy in HIV-1-Infected Patients With Resistance to at Least 2 Antiretroviral Classes. Open Forum Infectious Diseases. 2023; 10(11)DOI:10.1093/ofid/ofad542. PMID:38023553. IF:3.800(Q2/3D).
01/11/2023
Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer
Nadal E., Oré-Arce M., Remon J., Bernabé-Caro R., Covela-Rúa M., de Castro-Carpeño J., Massutí-Sureda B., Guillot-Morales M., Majem M., Maestu-Maiques I., Morilla-Ruíz I., Gironés R.. Expert consensus to optimize the management of older adult patients with advanced EGFR-mutated non-small cell lung cancer. Clinical & Translational Oncology. 2023; 25(11)DOI:10.1007/s12094-023-03286-3. PMID:37566345. IF:2.800(Q2/5D).
01/11/2023
Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation
Serna, N, López-Laguna, H, Aceituno, P, Rojas-Peña, M, Parladé, E, Voltà-Durán, E, Martínez-Torró, C, Sánchez, JM, Di Somma, A, Carratalá, JV, Livieri, AL, Ferrer-Miralles, N, Vázquez, E, Unzueta, U, Roher, N, Villaverde, A. Efficient Delivery of Antimicrobial Peptides in an Innovative, Slow-Release Pharmacological Formulation. Pharmaceutics. 2023; 15(11)DOI:10.3390/pharmaceutics15112632. PMID:38004610. IF:4.900(Q1/2D).
01/11/2023
Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy
León X., Llansana A., Pérez-Ugarte L., García J., Valero C., Quer M., Camacho M.. Predictive capacity of FAT1 transcriptional expression in patients with head and neck squamous cell carcinomas treated with radiotherapy. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.03.003. PMID:37931687. IF:(Q/D).
01/11/2023
Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis
Pujol A., Llansana A., Pérez-Ugarte L., Sauter B., Quer M., León X.. Second esophageal neoplasms after head and neck index tumor: Incidence, risk factors and prognosis. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2022.10.005. PMID:. IF:(Q/D).
01/11/2023
Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas
León, X, Bague, S, Holgado, A, Quer, M, Terra, X, Camacho, M, Aviltes-Jurado, FX. Relationship between transcriptional expression of pyruvate dehydrogenase and local control of disease in patients with oral cavity carcinomas. Acta Otorrinolaringologica Espanola. 2023; 74(6)DOI:10.1016/j.otorri.2023.05.001. PMID:. IF:(Q/D).
01/11/2023
[[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.
Puig L. [[Translated Article]]Race, Ethnicity, and Ancestry: A Short Review and Proposal for Consistent Classifications in Dermatology.. Actas Dermo-Sifiliograficas. 2023; 114(10)DOI:10.1016/j.ad.2023.09.020. PMID:37778620. IF:(Q/D).
31/10/2023
Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly
Marques-Pamies, M, Gil, J, Valassi, E, Hernández, M, Biagetti, B, Giménez-Palop, O, Martínez, S, Carrato, C, Pons, L, Villar-Taibo, R, Araujo-Castro, M, Blanco, C, Simón, I, Simó-Servat, A, Xifra, G, Vázquez, F, Pavón, I, García-Centeno, R, Zavala, R, Hanzu, FA, Mora, M, Aulinas, A, Vilarrasa, N, Librizzi, S, Calatayud, M, de Miguel, P, Alvarez-Escola, C, Picó, A, Sampedro, M, Salinas, I, Fajardo-Montañana, C, Cámara, R, Bernabéu, I, Jordà, M, Webb, SM, Marazuela, M, Puig-Domingo, M. Revisiting the usefulness of the short acute octreotide test to predict treatment outcomes in acromegaly. Frontiers in Endocrinology. 2023; 14DOI:10.3389/fendo.2023.1269787. PMID:38027102. IF:3.900(Q2/3D).
28/10/2023
Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum
Goossens, J, González, AC, Dewit, N, Lidón, L, Fortea, J, Alcolea, D, Lleó, A, Belbin, O, Vanmechelen, E. Evaluation of cerebrospinal fluid levels of synaptic vesicle protein, VAMP-2, across the sporadic Alzheimer's disease continuum. Alzheimers Research & Therapy. 2023; 15(1)DOI:10.1186/s13195-023-01336-0. PMID:37898760. IF:8.000(Q1/1D).
27/10/2023
Comparison of diluted vs concentrated regional citrate anticoagulation in continuous renal replacement therapy: A quasi-experimental study
Mateos-Dávila, A, Roig, AJB, Rodríguez, JAS, Guix-Comellas, EM. Comparison of diluted vs concentrated regional citrate anticoagulation in continuous renal replacement therapy: A quasi-experimental study. Nursing in Critical Care. 2023; DOI:10.1111/nicc.12991. PMID:37897131. IF:3.000(Q1/1D).
27/10/2023
Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine
Hueso, M, Rotllan, N, Escolà-Gil, JC, Vellido, A. Systems biology and data-driven machine learning-based models in personalized cardiovascular medicine. Frontiers in Cardiovascular Medicine. 2023; 10DOI:10.3389/fcvm.2023.1320110. PMID:37965080. IF:2.800(Q2/4D).
27/10/2023
Frontline therapy in Chronic Lymphocytic Leukemia
Arguello-Tomas, M, Albiol, N, Moreno, C. Frontline therapy in Chronic Lymphocytic Leukemia. ACTA HAEMATOLOGICA. 2023; 147(1)DOI:10.1159/000534730. PMID:37899041. IF:1.700(Q3/8D).
26/10/2023
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis
Kwatra, SG, Yosipovitch, G, Legat, FJ, Reich, A, Paul, C, Simon, D, Naldi, L, Lynde, C, De Bruin-Weller, MS, Nahm, WK, Sauder, M, Gharib, R, Barbarot, S, Szepietowski, JC, Conrad, C, Fleischer, A, Laquer, VT, Misery, L, Serra-Baldrich, E, Lapeere, H, Ahmad, F, Lopez, ZKJ, Piketty, C, Ständer, S. Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(17)DOI:10.1056/NEJMoa2301333. PMID:37888917. IF:96.300(Q1/1D).
25/10/2023
Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort
Broers, MC, Wieske, L, Erdag, E, Gürlek, C, Bunschoten, C, van Doorn, PA, Eftimov, F, Kuitwaard, K, de Vries, JM, de Wit, MCY, Nagtzaam, MMP, Franken, SC, Zhu, LIS, Paunovic, M, de Wit, M, Schreurs, MWJ, Lleixà, C, Martín-Aguilar, L, Pascual-Goñi, E, Querol, L, Jacobs, BC, Huizinga, R, Titulaer, MJ. Clinical relevance of distinguishing autoimmune nodopathies from CIDP: longitudinal assessment in a large cohort. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY. 2023; 95(1)DOI:10.1136/jnnp-2023-331378. PMID:37879898. IF:8.800(Q1/1D).
25/10/2023
A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study
Escobar, C, Freire, RB, Marimón, XGM, González-Juanatey, C, Morillas, M, Muñoz, AV, Doblas, JJG. A Delphi consensus on the management of anticoagulation in the COVID-19 pandemic: the MONACO study. Cardiovascular Diagnosis and Therapy. 2023; 13(5)DOI:10.21037/cdt-23-76. PMID:37941839. IF:2.000(Q3/6D).
25/10/2023
Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis
Juanola, A, Ma, AT, de Wit, K, Gananandan, K, Roux, O, Zaccherini, G, Jiménez, C, Tonon, M, Solé, C, Villaseca, C, Uschner, FE, Graupera, I, Pose, E, Moreta, MJ, Campion, D, Beuers, U, Mookerjee, RP, Francoz, C, Durand, F, Vargas, V, Piano, S, Alonso, S, Trebicka, J, Laleman, W, Asrani, SK, Soriano, G, Alessandria, C, Serra-Burriel, M, Morales-Ruiz, M, Torres, F, Allegretti, AS, Krag, A, Caraceni, P, Watson, H, Abraldes, JG, Sola, E, Kamath, PS, Hernaez, R, Ginès, P, LiverHope Investigators. Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis. GUT. 2023; DOI:10.1136/gutjnl-2023-329923. PMID:37884354. IF:23.100(Q1/1D).
23/10/2023
Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain
Valero-Martínez, C, Urgelles, JF, Sallés, M, Joven-Ibáñez, BE, de Juanes, A, Ramírez, J, Juanola, X, Almodóvar, R, Laiz, A, Moreno, M, Pujol, M, Beltrán, E, Pinto-Tasende, JA, Crespí, L, Sala-Icardo, L, Castañeda, S, García-Vicuña, R. Dual targeted therapy in patients with psoriatic arthritis and spondyloarthritis: a real-world multicenter experience from Spain. Frontiers in Immunology. 2023; 14DOI:10.3389/fimmu.2023.1283251. PMID:37936691. IF:5.700(Q1/3D).
21/10/2023
Hyperactive delirium during emergency department stay: analysis of risk factors and association with short-term outcomes
Miró Ò., Osorio G., Alquézar-Arbé A., Aguiló S., Fernández C., Burillo G., Jacob J., Llorens P., Llauger L., Peláez González Á., Figuera Castro E.R., Juarez González R., Blanco Hoffman M.J., Fernandez Salgado F., Pablos Pizarro T., Berenguer Díez M.A., Truyol Más M., López-Laguna N., Garcia Acosta J., Fernandez Domato C., Diego Robledo F.J., Ezponda P., Martinez Lorenzo A., Ortega Liarte J.V., García Rupérez I., Borne Jerez S., Corugedo Ovies C., Gallardo Sánchez B.A., Del Castillo J.G.. Hyperactive delirium during emergency department stay: analysis of risk factors and association with short-term outcomes. Internal and Emergency Medicine. 2023; 19(2)DOI:10.1007/s11739-023-03440-3. PMID:37865623. IF:3.200(Q1/2D).
21/10/2023
Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy
Socié G., Barba P., Barlev A., Sanz J., García-Cadenas I., Chevallier P., Fagioli F., Guzman-Becerra N., Kumar D., Ljungman P., Pigneux A., Sadetsky N., Yáñez San Segundo L., Shadman M., Storek J., Thirumalai D., Xing B., Mohty M.. Outcomes for patients with EBV-positive PTLD post-allogeneic HCT after failure of rituximab-containing therapy. BONE MARROW TRANSPLANTATION. 2023; 59(1)DOI:10.1038/s41409-023-02127-9. PMID:37865719. IF:4.500(Q1/2D).
20/10/2023
Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study
Meca-Lallana J.E., Prieto González J.M., Caminero Rodríguez A.B., Olascoaga Urtaza J., Alonso A.M., Durán Ferreras E., Espinosa R., Dotor J., Romera M., Ares Luque A., Pérez Ruiz D., Calles C., Hernández M.A., Hervás García M., Mendoza Rodríguez A., Berdei Montero Y., Téllez N., Herrera Varó N., Sotoca J., Presas-Rodríguez S., Querol Gutierrez L.A., Hervás Pujol M., Batlle Nadal J., Martín Ozaeta G., Gubieras Lillo L., Martínez Yélamos S., Ramió-Torrentà L., Mallada Frechin J., Belenguer Benavides A., Gascón-Giménez F., Casanova B., Landete Pascual L., Berenguer L., Navarro L., Gómez Gutierrez M., Durán C., Rodríguez Regal A., Álvarez E., García-Estévez D.A., López Real A.M., Llaneza González M.A., Marzo Sola M.E., Sánchez-Menoyo J.L., Oterino A., Villaverde González R., Castillo-Triviño T., Álvarez de Arcaya A., Llarena C.. Effectiveness and Safety of Teriflunomide in Relapsing–Remitting Multiple Sclerosis and Improvements in Quality of Life: Results from the Real-World TERICARE Study. Neurology and Therapy. 2023; 12(6)DOI:10.1007/s40120-023-00557-7. PMID:37861931. IF:4.000(Q1/2D).
20/10/2023
Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer
Ahn, MJ, Cho, BC, Felip, E, Korantzis, I, Ohashi, K, Majem, M, Juan-Vidal, O, Handzhiev, S, Izumi, H, Lee, JS, Dziadziuszko, R, Wolf, J, Blackhall, F, Reck, M, Alvarez, JB, Hummel, HD, Dingemans, AMC, Sands, J, Akamatsu, H, Owonikoko, TK, Ramalingam, SS, Borghaei, H, Johnson, ML, Huang, S, Mukherjee, S, Minocha, M, Jiang, TY, Martinez, P, Anderson, ES, Paz-Ares, L. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer. NEW ENGLAND JOURNAL OF MEDICINE. 2023; 389(22)DOI:10.1056/NEJMoa2307980. PMID:37861218. IF:96.300(Q1/1D).
20/10/2023
Spatial distribution and temporal dynamics of invasive and native mosquitoes in a large Mediterranean city
Ferraguti, M, Puente, JMD, Brugueras, S, Millet, JP, Rius, C, Valsecchi, A, Figuerola, J, Montalvo, T. Spatial distribution and temporal dynamics of invasive and native mosquitoes in a large Mediterranean city. The Science of the total environment. 2023; 896DOI:10.1016/j.scitotenv.2023.165322. PMID:37414178. IF:8.200(Q1/1D).
19/10/2023
If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression
Vicent-Gil, M, Trujols, J, Serra-Blasco, M, Navarra-Ventura, G, Puigdemont, D, Alemany, C, Crivillés, S, de Diego-Adeliño, J, Cardoner, N, Portella, MJ. If you feel you can't, you won't: the role of subjective and objective cognitive competence on psychosocial functioning in depression. EUROPEAN PSYCHIATRY. 2023; 66(1)DOI:10.1192/j.eurpsy.2023.2454. PMID:37855104. IF:7.200(Q1/1D).
18/10/2023
Where there is smoke there is risk: is there an irreversible threshold?
Garcia-Moll, X. Where there is smoke there is risk: is there an irreversible threshold?. EUROPEAN HEART JOURNAL. 2023; 44(42)DOI:10.1093/eurheartj/ehad685. PMID:37850511. IF:38.100(Q1/1D).
17/10/2023
Impact of functional dependency of elderly patients seen in Spanish emergency departments during the first wave of the COVID-19 pandemic on mortality at 30, 180 and 365 days depending on the diagnosis (COVID versus non-COVID)
Alonso, CF, Ferrer, MEF, García-Lamberechts, EJ, Mir, SA, Jiménez, S, Rodriguez, JJ, Salmerón, PP, Gil-Rodrigo, A, Llorens, P, Burillo-Putze, G, Pérez, FJM, Alquezar-Arbé, A, Gallardo, RR, Diez, MAB, Más, MT, López-Laguna, N, Soler, AC, Nespereira, EG, García, AG, Ezponda, P, Lorenzo, AM, Liarte, JVO, Martín, JMS, Puente, PH, Villalibre, AM, del Castillo, JG, Miró, O. Impact of functional dependency of elderly patients seen in Spanish emergency departments during the first wave of the COVID-19 pandemic on mortality at 30, 180 and 365 days depending on the diagnosis (COVID versus non-COVID). Revista Espanola de Salud Publica. 2023; 97DOI:. PMID:. IF:0.900(Q4/9D).
16/10/2023
New-onset heart failure in infants: when the aetiological diagnosis becomes a challenge
Esmel-Vilomara R., Riaza L., Dolader P., Sabaté-Rotés A., Rosés-Noguer F., Gran F.. New-onset heart failure in infants: when the aetiological diagnosis becomes a challenge. EUROPEAN JOURNAL OF PEDIATRICS. 2023; DOI:10.1007/s00431-023-05286-5. PMID:37843615. IF:3.000(Q1/2D).
16/10/2023
Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target
Roychowdhury T., Klarin D., Levin M.G., Spin J.M., Rhee Y.H., Deng A., Headley C.A., Tsao N.L., Gellatly C., Zuber V., Shen F., Hornsby W.E., Laursen I.H., Verma S.S., Locke A.E., Einarsson G., Thorleifsson G., Graham S.E., Dikilitas O., Pattee J.W., Judy R.L., Pauls-Verges F., Nielsen J.B., Wolford B.N., Brumpton B.M., Dilmé J., Peypoch O., Juscafresa L.C., Edwards T.L., Li D., Banasik K., Brunak S., Jacobsen R.L., Garcia-Barrio M.T., Zhang J., Rasmussen L.M., Lee R., Handa A., Wanhainen A., Mani K., Lindholt J.S., Obel L.M., Strauss E., Oszkinis G., Nelson C.P., Saxby K.L., van Herwaarden J.A., van der Laan S.W., van Setten J., Camacho M., Davis F.M., Wasikowski R., Tsoi L.C., Gudjonsson J.E., Eliason J.L., Coleman D.M., Henke P.K., Ganesh S.K., Chen Y.E., Guan W., Pankow J.S., Pankratz N., Pedersen O.B., Erikstrup C., Tang W., Hveem K., Gudbjartsson D., Gretarsdottir S., Thorsteinsdottir U., Holm H., Stefansson K., Ferreira M.A., Baras A., Kullo I.J., Ritchie M.D., Christensen A.H., Iversen K.K., Eldrup N., Sillesen H., Ostrowski S.R., Bundgaard H., Ullum H., Burgess S., Gill D., Gallagher K., Sabater-Lleal M., Dudbridge F., Samani N.J., Surakka I., Jones G.T., Bown M.J., Tsao P.S., Willer C.J., Damrauer S.M.. Genome-wide association meta-analysis identifies risk loci for abdominal aortic aneurysm and highlights PCSK9 as a therapeutic target. NATURE GENETICS. 2023; 55(11)DOI:10.1038/s41588-023-01510-y. PMID:37845353. IF:31.800(Q1/1D).
15/10/2023
High-precision targeting and destruction of cancer-associated PDGFR-ß(+) stromal fibroblasts through self-assembling, protein-only nanoparticles.
Voltà-Durán E, Alba-Castellón L, Serna N, Casanova I, López-Laguna H, Gallardo A, Sánchez-Chardi A, Villaverde A, Unzueta U, Vázquez E, Mangues R. High-precision targeting and destruction of cancer-associated PDGFR-ß(+) stromal fibroblasts through self-assembling, protein-only nanoparticles.. Acta Biomaterialia. 2023; 170DOI:10.1016/j.actbio.2023.09.001. PMID:37683965. IF:9.400(Q1/1D).
15/10/2023
SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.
Kulisevsky J, Esquivel A, Freire-Álvarez E, Gómez-Esteban JC, Legarda-Ramírez I, Mata-Álvarez-Santullano M. SYNAPSES. A European observational study to evaluate the safety and the effectiveness of safinamide in routine clinical practice: post-hoc analysis of the Spanish study population.. REVISTA DE NEUROLOGIA. 2023; 77(s02)DOI:10.33588/rn.77s02.2023217. PMID:37752685. IF:0.800(Q4/9D).
13/10/2023
Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib
Vallez-Valero L., Gasó-Gago I., Marcos-Fendian Á., Garrido-Alejos G., Riera-Magallón A., Plaza Diaz A., Martinez-Molina C., Mangues-Bafalluy M.A., Corominas H.. Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib. CLINICAL RHEUMATOLOGY. 2023; 42(12)DOI:10.1007/s10067-023-06787-2. PMID:37831336. IF:2.900(Q2/4D).
13/10/2023
Assessment of the degree of knowledge of the massive transfusion protocol in four Spanish hospitals
Rincón Ferrari M.D., Felipe Correoso M.M., Candela Toha Á.. Assessment of the degree of knowledge of the massive transfusion protocol in four Spanish hospitals. MEDICINA CLINICA. 2023; 161(7)DOI:10.1016/j.medcli.2023.05.010. PMID:37380548. IF:2.600(Q1/3D).
13/10/2023
Quality control to improve LDL-cholesterol management in patients with acute coronary syndromes based on the ACS EuroPath IV project
Schiele, F, Catapano, AL, De Caterina, R, Laufs, U, Jukema, JW, Zaman, A, Sionis, A. Quality control to improve LDL-cholesterol management in patients with acute coronary syndromes based on the ACS EuroPath IV project. European Heart Journal-Acute Cardiovascular Care. 2023; 13(1)DOI:10.1093/ehjacc/zuad119. PMID:37832522. IF:4.000(Q1/3D).
12/10/2023
Frequency, morbidity and equity - the case for increased research on male fertility
Kimmins, S, Anderson, RA, Barratt, CLR, Behre, HM, Catford, SR, De Jonge, CJ, Delbes, G, Eisenberg, ML, Garrido, N, Houston, BJ, Jorgensen, N, Krausz, C, Lismer, A, Mclachlan, RI, Minhas, S, Moss, T, Pacey, A, Priskorn, L, Schlatt, S, Trasler, J, Trasande, L, Tüttelmann, F, Vazquez-Levin, MH, Veltman, JA, Zhang, F, O'Bryan, MK. Frequency, morbidity and equity - the case for increased research on male fertility. Nature Reviews Urology. 2023; DOI:10.1038/s41585-023-00820-4. PMID:37828407. IF:12.100(Q1/1D).
12/10/2023
Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV)
Sánchez-Ceña J., Asmarats L., Li C.H.P., Millán X., Fernández-Peregrina E., Menduiña I., Massó van Roessel A., Arzamendi D.. Redo transcatheter aortic valve replacement in degenerated transcatheter bioprosthesis (TAV-in-TAV). Expert Review Of Cardiovascular Therapy. 2023; 21(10)DOI:10.1080/14779072.2023.2266368. PMID:37815845. IF:(Q/D).
12/10/2023
Editorial: Molecular, structural and electrophysiological remodeling in atrial fibrillation
Franco, D, Hove-Madsen, L, Daimi, H. Editorial: Molecular, structural and electrophysiological remodeling in atrial fibrillation. Frontiers in Physiology. 2023; 14DOI:10.3389/fphys.2023.1303328. PMID:37900957. IF:3.200(Q2/3D).
12/10/2023
Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline
Guiñón L., Illana F.J., Cuevas B., Canyelles M., Martínez-Bru C., García-Osuna Á.. Periodic verification of results' comparability between several analyzers: Experience in the application of the EP31-A-IR guideline. CLINICAL CHEMISTRY AND LABORATORY MEDICINE. 2023; 62(3)DOI:10.1515/cclm-2023-0994. PMID:37819627. IF:3.800(Q1/2D).
11/10/2023
Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units
Moraga P., Prieto P., Conradie A., Benhayoun M., Rousell V., Davy M., Fuhr U., Antonijoan Arbos R., Abad-Santos F., Portolés A., Van Duinen J., Carcas A.J., Borobia A.M.. Academia and industry agreement on a feasibility tool for first-time-in-human clinical trial units. CTS-Clinical and Translational Science. 2023; 16(12)DOI:10.1111/cts.13655. PMID:37818923. IF:3.100(Q2/5D).
10/10/2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome
van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. EUROPEAN JOURNAL OF NEUROLOGY. 2023; 30(12)DOI:10.1111/ene.16073. PMID:37814552. IF:4.500(Q1/2D).
10/10/2023
European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome
van Doorn P.A., Van den Bergh P.Y.K., Hadden R.D.M., Avau B., Vankrunkelsven P., Attarian S., Blomkwist-Markens P.H., Cornblath D.R., Goedee H.S., Harbo T., Jacobs B.C., Kusunoki S., Lehmann H.C., Lewis R.A., Lunn M.P., Nobile-Orazio E., Querol L., Rajabally Y.A., Umapathi T., Topaloglu H.A., Willison H.J.. European Academy of Neurology/Peripheral Nerve Society Guideline on diagnosis and treatment of Guillain–Barré syndrome. JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM. 2023; 28(4)DOI:10.1111/jns.12594. PMID:37814551. IF:4.000(Q1/2D).
05/10/2023
Surgical treatment of retrorectal tumors: a plea for a laparoscopic approach.
Galán C, Hernández MP, Martínez MC, Sánchez A, Bollo J, Targarona EM. Surgical treatment of retrorectal tumors: a plea for a laparoscopic approach.. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2023; 37(12)DOI:10.1007/s00464-023-10448-5. PMID:37798533. IF:2.400(Q1/3D).
05/10/2023
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.
Tobias DK, Merino J, Ahmad A, Aiken C, Benham JL, Bodhini D, Clark AL, Colclough K, Corcoy R, Cromer SJ, Duan D, Felton JL, Francis EC, Gillard P, Gingras V, Gaillard R, Haider E, Hughes A, Ikle JM, Jacobsen LM, Kahkoska AR, Kettunen JLT, Kreienkamp RJ, Lim LL, Männistö JME, Massey R, Mclennan NM, Miller RG, Morieri ML, Most J, Naylor RN, Ozkan B, Patel KA, Pilla SJ, Prystupa K, Raghavan S, Rooney MR, Schön M, Semnani-Azad Z, Sevilla-Gonzalez M, Svalastoga P, Takele WW, Tam CH, Thuesen ACB, Tosur M, Wallace AS, Wang CC, Wong JJ, Yamamoto JM, Young K, Amouyal C, Andersen MK, Bonham MP, Chen M, Cheng F, Chikowore T, Chivers SC, Clemmensen C, Dabelea D, Dawed AY, Deutsch AJ, Dickens LT, DiMeglio LA, Dudenhöffer-Pfeifer M, Evans-Molina C, Fernández-Balsells MM, Fitipaldi H, Fitzpatrick SL, Gitelman SE, Goodarzi MO, Grieger JA, Guasch-Ferré M, Habibi N, Hansen T, Huang C, Harris-Kawano A, Ismail HM, Hoag B, Johnson RK, Jones AG, Koivula RW, Leong A, Leung GKW, Libman IM, Liu K, Long SA, Lowe WL Jr, Morton RW, Motala AA, Onengut-Gumuscu S, Pankow JS, Pathirana M, Pazmino S, Perez D, Petrie JR, Powe CE, Quinteros A, Jain R, Ray D, Ried-Larsen M, Saeed Z, Santhakumar V, Kanbour S, Sarkar S, Monaco GSF, Scholtens DM, Selvin E, Sheu WH, Speake C, Stanislawski MA, Steenackers N, Steck AK, Stefan N, Støy J, Taylor R, Tye SC, Ukke GG, Urazbayeva M, Van der Schueren B, Vatier C, Wentworth JM, Hannah W, White SL, Yu G, Zhang Y, Zhou SJ, Beltrand J, Polak M, Aukrust I, de Franco E, Flanagan SE, Maloney KA, McGovern A, Molnes J, Nakabuye M, Njølstad PR, Pomares-Millan H, Provenzano M, Saint-Martin C, Zhang C, Zhu Y, Auh S, de Souza R, Fawcett AJ, Gruber C, Mekonnen EG, Mixter E, Sherifali D, Eckel RH, Nolan JJ, Philipson LH, Brown RJ, Billings LK, Boyle K, Costacou T, Dennis JM, Florez JC, Gloyn AL, Gomez MF, Gottlieb PA, Greeley SAW, Griffin K, Hattersley AT, Hirsch IB, Hivert MF, Hood KK, Josefson JL, Kwak SH, Laffel LM, Lim SS, Loos RJF, Ma RCW, Mathieu C, Mathioudakis N, Meigs JB, Misra S, Mohan V, Murphy R, Oram R, Owen KR, Ozanne SE, Pearson ER, Perng W, Pollin TI, Pop-Busui R, Pratley RE, Redman LM, Redondo MJ, Reynolds RM, Semple RK, Sherr JL, Sims EK, Sweeting A, Tuomi T, Udler MS, Vesco KK, Vilsbøll T, Wagner R, Rich SS, Franks PW. Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.. NATURE MEDICINE. 2023; 29(10)DOI:10.1038/s41591-023-02502-5. PMID:37794253. IF:58.700(Q1/1D).
04/10/2023
Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.
Neumann A, Ohlei O, Küçükali F, Bos IJ, Timsina J, Vos S, Prokopenko D, Tijms BM, Andreasson U, Blennow K, Vandenberghe R, Scheltens P, Teunissen CE, Engelborghs S, Frisoni GB, Blin O, Richardson JC, Bordet R, Lleó A, Alcolea D, Popp J, Marsh TW, Gorijala P, Clark C, Peyratout G, Martinez-Lage P, Tainta M, Dobson RJB, Legido-Quigley C, Van Broeckhoven C, Tanzi RE, Ten Kate M, Lill CM, Barkhof F, Cruchaga C, Lovestone S, Streffer J, Zetterberg H, Visser PJ, Sleegers K, Bertram L. Multivariate GWAS of Alzheimer's disease CSF biomarker profiles implies GRIN2D in synaptic functioning.. Genome Medicine. 2023; 15(1)DOI:10.1186/s13073-023-01233-z. PMID:37794492. IF:10.400(Q1/1D).
04/10/2023
Perceptions and attitudes regarding delayed antibiotic prescription for respiratory tract infections: a qualitative study.
Mas-Dalmau G, Pequeño-Saco S, de la Poza-Abad M, Borrell-Thió E, Besa-Castellà M, Alsina-Casalduero M, Cuixart-Costa L, Liroz-Navarro M, Calderón-Gómez C, Martí J, Cruz-Gómez I, Alonso-Coello P. Perceptions and attitudes regarding delayed antibiotic prescription for respiratory tract infections: a qualitative study.. Bmc Primary Care. 2023; 24(1)DOI:10.1186/s12875-023-02123-4. PMID:37794330. IF:2.000(Q2/4D).
03/10/2023
How oral health care organizations formulate actionable statements to inform practice and policy: A protocol for a systematic survey.
Verdugo-Paiva F, Bonfill Cosp X, Alonso-Coello P, Ávila-Oliver C, Glick M, Carrasco-Labra A. How oral health care organizations formulate actionable statements to inform practice and policy: A protocol for a systematic survey.. F1000research. 2023; 12DOI:10.12688/f1000research.141423.1. PMID:37981981. IF:(Q/D).
03/10/2023
Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.
Scévola S, Niubó J, Domingo P, Verdejo G, Curran A, Diaz-Brito V, Peñafiel J, Tiraboschi J, Morenilla S, Garcia B, Soriano I, Podzamczer D, Imaz A. Decay of HIV RNA in Seminal Plasma and Rectal Fluid in Treatment-Naive Adults Starting Antiretroviral Therapy With Dolutegravir Plus Lamivudine or Bictegravir/Emtricitabine/Tenofovir Alafenamide.. JOURNAL OF INFECTIOUS DISEASES. 2023; 228(7)DOI:10.1093/infdis/jiad304. PMID:37526315. IF:(Q/D).
02/10/2023
Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.
Baron F, Nagler A, Galimard JE, Sanz J, Versluis J, Forcade E, Chevallier P, Sirvent A, Anthias C, Kuball J, Furst S, Rambaldi A, Sierra J, von dem Borne PA, Gallego Hernanz MP, Cluzeau T, Robinson S, Raiola AM, Labussière-Wallet H, Byrne JL, Malfuson JV, Ruggeri A, Mohty M, Ciceri F. Cord blood transplantation for AML: Comparable LFS in patients with de novo versus secondary AML in CR1, an ALWP/EBMT study.. BRITISH JOURNAL OF HAEMATOLOGY. 2023; 204(1)DOI:10.1111/bjh.19130. PMID:37784256. IF:5.100(Q1/2D).
02/10/2023
Assessing the magnitude of changes from protocol to publication-a survey on Cochrane and non-Cochrane Systematic Reviews.
Siebert M, Caquelin L, Madera M, Acosta-Dighero R, Naudet F, Roqué M. Assessing the magnitude of changes from protocol to publication-a survey on Cochrane and non-Cochrane Systematic Reviews.. PeerJ. 2023; 11DOI:10.7717/peerj.16016. PMID:37810785. IF:2.300(Q2/4D).
01/10/2023
Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway
Pérez-Fernández, M, Suárez-Rojas, I, Bai, X, Martínez-Martel, I, Ciaffaglione, V, Pittalà, V, Salerno, L, Pol, O. Novel Heme Oxygenase-1 Inducers Palliate Inflammatory Pain and Emotional Disorders by Regulating NLRP3 Inflammasome and Activating the Antioxidant Pathway. Antioxidants. 2023; 12(10)DOI:10.3390/antiox12101794. PMID:37891874. IF:6.000(Q1/2D).
01/10/2023
The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated
Suárez-Rojas, I, Pérez-Fernández, M, Bai, X, Martínez-Martel, I, Intagliata, S, Pittalà, V, Salerno, L, Pol, O. The Inhibition of Neuropathic Pain Incited by Nerve Injury and Accompanying Mood Disorders by New Heme Oxygenase-1 Inducers: Mechanisms Implicated. Antioxidants. 2023; 12(10)DOI:10.3390/antiox12101859. PMID:37891937. IF:6.000(Q1/2D).
01/10/2023
“Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”
Cerdán-Santacruz C., Cano-Valderrama Ó., Santos Rancaño R., Terés L.B., Vigorita V., Pérez T.P., Rosciano Paganelli J.G., Paredes Cotoré J.P., Carre M.K., Flor-Lorente B., Antona F.B., Martín E.Y., Tebar J.C., Cao I.A., Coltell Z.B., Alonso M.G., Prada López B.L., Riesco A.B., Cánovas N.I., Sánchez C.M., Serrat D.R., Conde G.A., Toscano M.J., Aira A.C., Pérez M.R., Petit N.M., Espín Basany E., Carré M.K., Pellino G., Retuerta J.M., Saldaña A.G., Laso C.Á., Allende I.A., Álvarez D.H., Cazador A.C., Sánchez Bautista W.M., Torres Sánchez M.T., Bonito A.C., Velázquez M.C., Díaz O.M., Fuentes N.S., Olías M.D.C.D.L.V., Lorente B.F., Valderrama Ó.C., Santacruz C.C.. “Long-term oncologic outcomes and risk factors for distant recurrence after pathologic complete response following neoadjuvant treatment for locally advanced rectal cancer. A nationwide, multicentre study”. EJSO. 2023; 49(10)DOI:10.1016/j.ejso.2023.06.014. PMID:37414628. IF:3.500(Q1/2D).
01/10/2023
Effect of high-intensity interval training compared to moderate-intensity continuous training on body composition and insulin sensitivity in overweight and obese adults: A systematic review and meta-analysis
Sanca-Valeriano, S, Espinola-Sánchez, M, Caballero-Alvarado, J, Canelo-Aybar, C. Effect of high-intensity interval training compared to moderate-intensity continuous training on body composition and insulin sensitivity in overweight and obese adults: A systematic review and meta-analysis. Heliyon. 2023; 9(10)DOI:10.1016/j.heliyon.2023.e20402. PMID:37800068. IF:3.400(Q1/3D).
01/10/2023
Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia
Ceccato, A, Camprubi-Rimblas, M, Bos, LDJ, Povoa, P, Martin-Loeches, I, Forne, C, Areny-Balaguero, A, Campaña-Duel, E, Morales-Quinteros, L, Quero, S, Ramirez, P, Esperatti, M, Torres, A, Blanch, L, Artigas, A. Evaluation of the Kinetics of Pancreatic Stone Protein as a Predictor of Ventilator-Associated Pneumonia. Biomedicines. 2023; 11(10)DOI:10.3390/biomedicines11102676. PMID:37893050. IF:3.900(Q1/3D).
01/10/2023
Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group
Nezvalova-Henriksen K., Langebrake C., Bauters T., Moreno-Martinez M.-E., Ahnfelt E., Ekelund H., Domingos V., Pires V., Bonnin A., Bojanic I., Cabrerizo Y., Terwel S., Tam A.. Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy-a guidance by the GoCART Coalition Pharmacist Working Group. BONE MARROW TRANSPLANTATION. 2023; 58(10)DOI:10.1038/s41409-023-02072-7. PMID:37528237. IF:4.500(Q1/2D).
01/10/2023
GEMA 5.3. Spanish Guideline on the Management of Asthma
Plaza Moral V., Alobid I., Álvarez Rodríguez C., Blanco Aparicio M., Ferreira J., García G., Gómez-Outes A., Garín Escrivá N., Gómez Ruiz F., Hidalgo Requena A., Korta Murua J., Molina París J., Pellegrini Belinchón F.J., Plaza Zamora J., Praena Crespo M., Quirce Gancedo S., Sanz Ortega J., Soto Campos J.G.. GEMA 5.3. Spanish Guideline on the Management of Asthma. Open Respiratory Archives. 2023; 5(4)DOI:10.1016/j.opresp.2023.100277. PMID:37886027. IF:(Q/D).
01/10/2023
The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department
Ruiz-Ramos, J, Escolà-Vergé, L, Monje-López, AE, Herrera-Mateo, S, Rivera, A. The Interventions and Challenges of Antimicrobial Stewardship in the Emergency Department. Antibiotics-Basel. 2023; 12(10)DOI:10.3390/antibiotics12101522. PMID:37887223. IF:4.300(Q1/2D).
01/10/2023
The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.
Rivera-Díaz R, Pozo T, Alfageme F, Díaz Ley B, Osorio GF, Chico R, Vilarrasa E, Silvente C, Ciudad Blanco C, Romaní J, Martorell A, Fernández P, Romero Ferreiro C, Molina Leyva A. The Effectiveness of Guselkumab in Patients With Hidradenitis Suppurativa Under Clinical Practice Conditions: A Spanish Multicentre Retrospective Study.. Actas Dermo-Sifiliograficas. 2023; 114(9)DOI:10.1016/j.ad.2023.06.018. PMID:37479135. IF:(Q/D).
01/10/2023
Practical aspects of PD-L1 assessment in the treatment of urothelial carcinoma: Consensus of the uropathology group of the SEAP
López-Beltrán A., González-Peramato P., Sanz-Ortega J., Prieto Cuadra J.D., Trias I., Luque Barona R.J., Semidey M.E., Maroto P., Algaba F.. Practical aspects of PD-L1 assessment in the treatment of urothelial carcinoma: Consensus of the uropathology group of the SEAP. Revista Espanola De Patologia. 2023; 56(4)DOI:10.1016/j.patol.2023.05.001. PMID:37879823. IF:(Q/D).
01/10/2023
Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.
Canyelles M, Blanco-Vaca F, Pérez A, Escolà-Gil JC. Comment on Huh et al. Remnant Cholesterol Is an Independent Predictor of Type 2 Diabetes: A Nationwide Population-Based Cohort Study. Diabetes Care 2023;46:305-312.. DIABETES CARE. 2023; 46(10)DOI:10.2337/dc23-0774. PMID:37729500. IF:(Q/D).
01/10/2023
Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.
Momblan D, Gimeno Garcia AZ, Busquets D, Juzgado D, García Lledó J, Ferrero E, Tejedor-Tejada J, Junquera F, Díaz-Tasende J, Moris M, Rodriguez de Santiago E, Gornals J, Garrido C, Gonzalez-Vazquez S, Guarner-Argente C, Repiso A, Esteban JM, Loras C, Seoane A, Fernández-Simon A, Guevara HC, Ibarzabal A, Morales X, Curell A, Cardenas A, Ríos J, de Lacy AM, Sendino O. Endoscopic Vacuum Therapy for Upper Gastrointestinal Leaks and Perforations: Analysis From a Multicenter Spanish Registry.. AMERICAN JOURNAL OF GASTROENTEROLOGY. 2023; 118(10)DOI:10.14309/ajg.0000000000002475. PMID:37606066. IF:8.500(Q1/1D).
01/10/2023
Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.
Lasaga M, Río P, Vilas-Zornoza A, Planell N, Navarro S, Alignani D, Fernández-Varas B, Mouzo D, Zubicaray J, Pujol RM, Nicoletti E, Schwartz JD, Sevilla J, Ainciburi M, Ullate-Agote A, Surrallés J, Perona R, Sastre L, Prosper F, Gomez-Cabrero D, Bueren JA. Gene therapy restores the transcriptional program of hematopoietic stem cells in Fanconi anemia.. HAEMATOLOGICA. 2023; 108(10)DOI:10.3324/haematol.2022.282418. PMID:37021532. IF:10.100(Q1/2D).